Efficacy and safety of the biosimilar Infliximab in the patients with Crohn's disease
Not Applicable
- Conditions
- Crohn disease
- Registration Number
- JPRN-UMIN000026330
- Lead Sponsor
- niversity of Toyama
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients younger than 20 years old 2) Patients keeping in the clinical remission state for more than 10 years
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method